Involvement of c-Met/Hepatocyte Growth Factor Pathway in Cholangiocarcinoma Cell Invasion and Its Therapeutic Inhibition With Small Interfering RNA Specific for c-Met-Reference-Cited by-同舟云学术

Involvement of c-Met/Hepatocyte Growth Factor Pathway in Cholangiocarcinoma Cell Invasion and Its Therapeutic Inhibition With Small Interfering RNA Specific for c-Met

Published:2006-11 Issue:1 Volume:136 Page:78-84
ISSN:0022-4804
Container-title:Journal of Surgical Research
language:en
Short-container-title:Journal of Surgical Research

Author:

Leelawat Kawin,Leelawat Surang,Tepaksorn Panada,Rattanasinganchan Panthip,Leungchaweng Anicha,Tohtong Rutaiwan,Sobhon Prasert

Publisher

Elsevier BV

Subject

Surgery

Reference16 articles.

1. Hilar cholangiocarcinoma: A review and commentary;Chamberlain;Ann Surg Oncol,2000

2. Aggressive surgical resection for cholangiocarcinoma;Washburn;Arch Surg,1995

3. Expression of the c-Met in advanced epithelial ovarian cancer and its prognostic significance;Ayhan;Int J Gynecol Cancer,2005

4. Role of the MET/HGF receptor in proliferation and invasive behavior of osteosarcoma;Coltella;FASEB J,2003

5. Overexpression and activation of hepatocyte growth factor/scatter factor in human non-small-cell lung carcinomas;Olivero;Br J Cancer,1996

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Precision immunotherapy for cholangiocarcinoma: Pioneering the use of human-derived anti-cMET single chain variable fragment in anti-cMET chimeric antigen receptor (CAR) NK cells;International Immunopharmacology;2024-07

2. Sulfasalazine inhibits esophageal cancer cell proliferation by mediating ferroptosis;Chemical Biology & Drug Design;2023-06-08

3. MUG CCArly: A Novel Autologous 3D Cholangiocarcinoma Model Presents an Increased Angiogenic Potential;Cancers;2023-03-14

4. Suppressing of Src–Hic-5–JNK–AKT Signaling Reduced GAPDH Expression for Preventing the Progression of HuCCT1 Cholangiocarcinoma;Pharmaceutics;2022-12-02

5. Antitumor Effects of Delta (9)-Tetrahydrocannabinol and Cannabinol on Cholangiocarcinoma Cells and Xenograft Mouse Models;Evidence-Based Complementary and Alternative Medicine;2022-11-21